MyFinsight
Home
Blog
About
Contact
Download
Download image
Digital assets
$2,454,473
Other prepaid
expenses
$61,839
Prepaid insurance
$29,490
Cash
$2,887,874
Total current assets
$5,433,676
Total assets
$5,433,676
Total liabilities and
stockholders equity
$5,433,676
Total stockholders
equity
$4,912,254
Total current
liabilities
$521,422
Accumulated deficit
-$55,533,319
Additional paid-in capital
$57,891,644
Series b convertible
preferred stock 8...
$50,367
Research and development
contract liabilities
$235,155
Accounts payable and
accrued expenses,...
$235,900
Common stock, 0.0001
par value...
$570
Preferred stock,
value-Series BConvertible...
$2,553,359
Back
Back
Balance Sheet
source: myfinsight.com
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)